Literature DB >> 6436873

Transdermally applied scopolamine does not impair psychomotor performance.

C H Gleiter, K H Antonin, P R Bieck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6436873     DOI： 10.1007/bf00428554

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  3 in total

1.  A comparison of plasma levels of hyoscine after oral and transdermal administration.

Authors:  C Muir; R Metcalfe
Journal:  J Pharm Biomed Anal       Date:  1983       Impact factor: 3.935

2.  Effects of scopolamine and nicotine on human rapid information processing performance.

Authors:  K Wesnes; D M Warburton
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

3.  Transdermal scopolamine in the prevention of motion sickness at sea.

Authors:  N M Price; L G Schmitt; J McGuire; J E Shaw; G Trobough
Journal:  Clin Pharmacol Ther       Date:  1981-03       Impact factor: 6.875
  3 in total
  1 in total

Review 1.  Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications.

Authors:  Zohar Nachum; Avi Shupak; Carlos R Gordon
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.